Glycosaminoglycans in Prophylaxis Against Venous Thromboembolism
- 1 January 1992
- book chapter
- Published by Springer Nature
- Vol. 313, 259-274
- https://doi.org/10.1007/978-1-4899-2444-5_26
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Low molecular weight heparin for thromboprophylaxis and epidural/spinal anaesthesia – is there a risk?Acta Anaesthesiologica Scandinavica, 1992
- Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight HeparinsDrugs, 1990
- Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosisBritish Journal of Surgery, 1988
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988
- Failure in prophylactic management of thromboembolic disease in colorectal surgeryDiseases of the Colon & Rectum, 1988
- Comparison of Low Molecular Weight Heparin vs. Unfractionated Heparin in Gynecological SurgeryActa Obstetricia et Gynecologica Scandinavica, 1988
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- Adjusted versus Fixed-Dose Subcutaneous Heparin in the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 1983
- Prevention of fatal postoperative pulmonary embolism by heparin dihydroergotamine or Dextran 70British Journal of Surgery, 1982
- A HEPARIN ANALOGUE WITH SPECIFIC ACTION ON ANTITHROMBIN IIIThe Lancet, 1977